Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

11.41 0.41 −3.47%
Market cap
$475.8M
P/E
24.8×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
6 7 6 7

+8 more TTM periods

ROE
12.82% 12.55% 11.18% 10.95%
ROA
8.09% 8.06% 7.30% 6.75%
ROIC
29.98% 22.79% 71.48% 0.00%
Return on Tangible Assets
15.84% 15.65% 12.19% 10.82%
Average Days of Receivables
42.29 48.89 28.73 38.13
Free Cash Flow per Share
0.30 0.61 0.80 0.47
Free Cash Flow
5.79 11.58 15.15 18.34
Other line items

Show all line items

Columns are period end dates